Safety and Efficacy of BAY 50-4798 in Patients With HIV Infection

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2003
The purpose of this study is to evaluate the safety of the experimental drug Bay 50-4798 in HIV positive patients receiving HAART and to test the drug\'s effect on the CD4+ T-cell count.
Epistemonikos ID: 5d30d78568b2be8c65869285ae0916a27c39b14f
First added on: Dec 01, 2021